Revival recalls canine milk replacers over vitamin D variability: full analysis

Revival Animal Health is recalling select canine milk replacers after finding variable vitamin D levels in products sold under its Breeder’s Edge Foster Care and Shelter’s Choice brands. The FDA posted the company’s recall announcement on April 17, 2026, saying some lots contained elevated vitamin D levels that may trigger toxicosis, while others contained low levels that may leave puppies under-supplemented. The recall covers products sold nationwide through e-commerce and retail pet stores. (fda.gov)

What makes this recall different from a more typical nutrient overage event is that it appears to cut in two directions at once. According to the FDA notice, the company’s investigation found both low and elevated vitamin D levels across affected milk replacers. That helps explain why the agency’s public warning includes classic toxicity signs, such as vomiting, anorexia, increased thirst and urination, drooling, weight loss, and possible renal dysfunction, while also reporting two complaints of rickets to date. In other words, clinicians may be dealing with either toxicosis or deficiency depending on the product and lot involved. (fda.gov)

The recall includes seven product configurations: Shelter’s Choice Canine Milk Replacer in 1 lb., 3.5 lb., and 8 lb. bags, and Breeder’s Edge Foster Care Canine Milk Replacer in 12 oz, 4.5 lb., 18 lb., and 20 lb. packages. Best-by dates listed by FDA run from May 22, 2026, through February 5, 2028. Pet parents are being told to stop feeding affected products immediately and contact the company for a refund. Revival said the recall is being conducted with FDA’s knowledge. (fda.gov)

From a clinical standpoint, vitamin D exposure matters because dogs rely on dietary intake rather than meaningful cutaneous synthesis. Merck Veterinary Manual says excess vitamin D disrupts calcium homeostasis, driving hypercalcemia and hyperphosphatemia and potentially causing soft-tissue mineralization, including renal injury. It also notes that clinical effects can be prolonged and may require weeks of monitoring and treatment adjustments. That’s especially relevant in puppies, where even short periods of nutritional imbalance can have outsized effects on hydration, growth, and skeletal development. (merckvetmanual.com)

Broader industry context also matters here. Vitamin D has been implicated in prior pet food recalls, including high-profile dog food recalls tied to formulation or supplier errors, which have put a spotlight on premix control and finished-product testing. While this Revival recall involves milk replacers rather than complete maintenance diets, it lands in a category where consistency is arguably even more important because the products may be used as a primary or sole food source in neonatal care. That raises the stakes for quality assurance, lot traceability, and rapid communication with breeders, shelters, rescues, and veterinary teams. (petfoodindustry.com)

Why it matters: For veterinarians, ER teams, and shelter clinicians, this is a history-taking story as much as a recall story. Puppies presenting with vomiting, failure to thrive, poor weight gain, PU/PD, dehydration, lameness, or skeletal abnormalities may warrant questions about recent use of Breeder’s Edge or Shelter’s Choice milk replacers and a check of product size and best-by date. Depending on the case, workups may need to include calcium, phosphorus, renal values, and imaging or orthopedic assessment, while treatment plans will differ substantially if the dominant issue is hypervitaminosis D versus deficiency-associated bone disease. (fda.gov)

What to watch: The next key developments are whether additional adverse events emerge, whether the affected scope changes, and whether FDA or the company provides more detail on the manufacturing or formulation failure that produced such wide vitamin D variability. For practices, the practical near-term issue is client communication: identifying exposed puppies quickly, advising pet parents to stop use, and triaging which animals need immediate evaluation versus monitoring. (fda.gov)